Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Collegium Pharmaceutical, Inc.”

27 pharma patents match "Collegium Pharmaceutical, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 27
Index total 30,257
Page 1 / 2

Quick answer

This filtered view shows 27 pharmaceutical patents matching "Collegium Pharmaceutical, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

27 results for “Collegium Pharmaceutical, Inc.” · 30,257 patents in full index Clear search

  1. US 10668060

    Tamper-resistant pharmaceutical compositions of opioids and other drugs

    Collegium Pharmaceutical, Inc. · Granted Jun 2, 2020 · Expires May 28, 2040

    granted

  2. US 10646485

    Process of making stable abuse-deterrent oral formulations

    Collegium Pharmaceutical, Inc. · Granted May 12, 2020 · Expires May 7, 2040

    granted

  3. US 10525052

    Abuse-deterrent drug formulations

    Collegium Pharmaceutical, Inc. · Granted Jan 7, 2020 · Expires Jan 2, 2040

    granted

  4. US 10525053

    Abuse-deterrent pharmaceutical compositions of opioids and other drugs

    Collegium Pharmaceutical, Inc. · Granted Jan 7, 2020 · Expires Jan 2, 2040

    granted

  5. US 10188644

    Process of making stable abuse-deterrent oral formulations

    Collegium Pharmaceutical, Inc. · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted

  6. US 10004729

    Tamper-resistant pharmaceutical compositions of opioids and other drugs

    Collegium Pharmaceutical, Inc. · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted

  7. US 9968598

    Process of making stable abuse-deterrent oral formulations

    Collegium Pharmaceutical, Inc. · Granted May 15, 2018 · Expires May 10, 2038

    granted

  8. US 9763883

    Abuse-deterrent drug formulations

    Collegium Pharmaceutical, Inc. · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted

  9. US 9737530

    Process of making stable abuse-deterrent oral formulations

    Collegium Pharmaceutical, Inc. · Granted Aug 22, 2017 · Expires Aug 17, 2037

    granted

  10. US 9682075

    Tamper-resistant pharmaceutical compositions of opioids and other drugs

    Collegium Pharmaceutical, Inc. · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted

  11. US 9592200

    Abuse-deterrent pharmaceutical compositions of opioids and other drugs

    Collegium Pharmaceutical, Inc. · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted

  12. US 9248195

    Abuse-deterrent pharmaceutical compositions of opioids and other drugs

    Collegium Pharmaceutical, Inc. · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted

  13. US 9044398

    Abuse-deterrent pharmaceutical compositions of opiods and other drugs

    Collegium Pharmaceutical, Inc. · Granted Jun 2, 2015 · Expires May 28, 2035

    granted

  14. US 8840928

    Tamper-resistant pharmaceutical compositions of opioids and other drugs

    Collegium Pharmaceutical, Inc. · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted

  15. US 8758813

    Abuse-deterrent drug formulations

    Collegium Pharmaceutical, Inc. · Granted Jun 24, 2014 · Expires Jun 19, 2034

    granted

  16. US 8557291

    Abuse-deterrent pharmaceutical compositions of opioids and other drugs

    Collegium Pharmaceutical, Inc. · Granted Oct 15, 2013 · Expires Oct 10, 2033

    granted

  17. US 8512751

    Pharmaceutical compositions for sleep disorders

    Collegium Pharmaceutical, Inc. · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted

  18. US 8449909

    Abuse-deterrent drug formulations

    Collegium Pharmaceutical, Inc. · Granted May 28, 2013 · Expires May 23, 2033

    granted

  19. US 8021687

    Modified release compositions of milnacipran

    Collegium Pharmaceutical, Inc. · Granted Sep 20, 2011 · Expires Sep 15, 2031

    granted

  20. US 7771707

    Abuse-deterrent drug formulations

    Collegium Pharmaceutical, Inc. · Granted Aug 10, 2010 · Expires Aug 5, 2030

    granted

  21. US 7704527

    Modified release compositions of milnacipran

    Collegium Pharmaceutical, Inc. · Granted Apr 27, 2010 · Expires Apr 22, 2030

    granted

  22. US 7585520

    Compositions containing both sedative and non-sedative antihistamines and sleep aids

    Collegium Pharmaceutical, Inc. · Granted Sep 8, 2009 · Expires Sep 3, 2029

    granted

  23. US 7399488

    Abuse-deterrent pharmaceutical compositions of opiods and other drugs

    Collegium Pharmaceutical, Inc. · Granted Jul 15, 2008 · Expires Jul 10, 2028

    granted

  24. US 7387792

    Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration

    Collegium Pharmaceutical, Inc. · Granted Jun 17, 2008 · Expires Jun 12, 2028

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.